DocuSign Insider Notice: 728 Shares Planned Sale via Morgan Stanley

Rhea-AI Filing Summary

Form 144 filed for DOCU discloses a proposed sale of 728 shares of DocuSign common stock through Morgan Stanley Smith Barney LLC, with an aggregate market value of $58,458.40. The filing lists the approximate date of sale as 09/15/2025 and reports total shares outstanding as 201,104,117. The shares were acquired as restricted stock from the issuer on 08/29/2025 (365 shares) and 09/04/2025 (363 shares), with payment recorded on those same dates. The filer attests they have no undisclosed material information and certifies the accuracy of the notice.

Insights

Securities Compliance Analyst

TL;DR: Routine insider sale notice of a small number of restricted shares; compliance disclosure appears complete.

The Form 144 documents a planned sale of 728 restricted shares by a person who acquired the shares from the issuer on 08/29/2025 and 09/04/2025. The broker is Morgan Stanley Smith Barney LLC and the intended sale date is 09/15/2025. The aggregate market value reported is $58,458.40 against reported outstanding shares of 201,104,117, indicating the transaction is immaterial to total capitalization. From a compliance perspective, the filing includes required acquisition dates, nature of acquisition, broker details, and the seller's representation regarding material nonpublic information, which are the primary elements regulators review for Rule 144 notices.

Equity Risk Analyst

TL;DR: Transaction size is negligible versus outstanding shares; unlikely to move market or signal major insider change.

The sale totals 728 shares acquired as restricted stock, split between two close acquisition dates. With an aggregate value of $58,458.40 relative to 201,104,117 shares outstanding, this disposal represents a de minimis percentage of float. There are no reported securities sold in the prior three months, and no indication of nonroutine conditions. For investors, this filing signals standard post-vesting or post-grant liquidity rather than a material transfer affecting ownership control or company valuation.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	728	58458.40	201104117	09/15/2025	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	09/04/2025	Restricted Stock	ISSUER			363	09/04/2025	Not Applicable
Common	08/29/2025	Restricted Stock	ISSUER			365	08/29/2025	Not Applicable

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does DOCU Form 144 report?

It reports a proposed sale of 728 shares of DocuSign common stock via Morgan Stanley Smith Barney LLC with aggregate market value of $58,458.40 and intended sale date 09/15/2025.

How were the shares acquired according to the filing?

The shares were acquired as restricted stock from the issuer on 08/29/2025 (365 shares) and 09/04/2025 (363 shares), with payment recorded on those dates.

Does the filing indicate material undisclosed information?

The filer represents they do not know any material adverse information about the issuer that has not been publicly disclosed.

Who is the broker handling the proposed sale?

Morgan Stanley Smith Barney LLC, Executive Financial Services, 1 New York Plaza, New York, NY is specified as the broker.

Were any other securities of the issuer sold by this person in the past three months?

No. The filing states 'Nothing to Report' for securities sold during the past three months.